Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01002313 · ClinicalTrials.gov registry record
Effect of Prednisone onTregs and TH17
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 40
- Enrollment target
NCT01002313: Completed study, sponsored by University of Chicago.
NCT01002313 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01002313 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The primary objective of this study is to see whether systemic corticosteroids (such as Prednisone) have an effect on the peripheral blood Treg and Th17 function in patients with CRS. Patients are taking prednisone as part of their routine medical care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-12 |
What the finished NCT01002313 record still lists
NCT01002313 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01002313 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01002313 about?
NCT01002313 is a clinical study titled "Effect of Prednisone onTregs and TH17". The primary objective of this study is to see whether systemic corticosteroids (such as Prednisone) have an effect on the peripheral blood Treg and Th17 function in patients with CRS. Patients are taking prednisone as part of their routine medical care.
What is the current status of trial NCT01002313?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2009-11. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT01002313?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia